GCP
STIM icon

GSA Capital Partners’s Neuronetics STIM Stock Holding History

GSA Capital Partners’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-97,889
Closed -$360K – 2128
2025
Q1 		$360K Sell
97,889
-19,253
-16% -$70.3K 0.03% 1027
2024
Q4 		$189K Buy
117,142
+38,500
+49% +$40K 0.01% 1429
2024
Q3 		$60K Buy
78,642
+30,837
+65% +$40.5K ﹤0.01% 1515
2024
Q2 		$86K Buy
+47,805
New +$138K 0.01% 1538
2020
Q2 		– Sell
-44,652
Closed -$84K – 1080
2020
Q1 		$84K Buy
+44,652
New +$140K 0.02% 923
2019
Q2 		– Sell
-13,000
Closed -$198K – 1716
2019
Q1 		$198K Buy
13,000
+1,300
+11% +$21.5K 0.02% 1242
2018
Q4 		$226K Buy
+11,700
New +$257K 0.03% 1024

Other funds holding STIM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $302M AUM 117.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

GSA Capital Partners's STIM Position: Q2 2025 in Review

GSA Capital Partners sold out of Neuronetics (STIM) in Q2 2025, closing a stake of 97,889 shares — an estimated $360K sold.

GSA Capital Partners first reported a position in STIM in Q4 2018 and held it in 7 quarters. The position peaked at $360K in Q1 2025. 90 funds tracked by Wall St. Rank hold STIM as of Q2 2025.

  • GSA Capital Partners reported no remaining Neuronetics position as of Q2 2025 after selling out during the quarter.
  • GSA Capital Partners sold 97,889 Neuronetics shares in Q2 2025, an estimated $360K.
  • GSA Capital Partners first reported a position in Neuronetics in Q4 2018 and held it in 7 quarters.
  • GSA Capital Partners's Neuronetics position peaked at $360K in Q1 2025.
  • 90 funds tracked by Wall St. Rank held Neuronetics as of Q2 2025.

Based on GSA Capital Partners's 13F filing for Q2 2025, filed 22 Jul 2025.